Endothelial dysfunction, arterial stiffness, and heart failure

Journal of the American College of Cardiology

Volumn 60, Issue 16, 2012, Pages 1455-1469

  Marti, Catherine N ^a   Gheorghiade, Mihai ^b   Kalogeropoulos, Andreas P ^a   Georgiopoulou, Vasiliki V ^a   Quyyumi, Arshed A ^a   Butler, Javed ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

arterial stiffness; endothelial function; heart failure

Indexed keywords

ALDOSTERONE ANTAGONIST; ALLOPURINOL; ALPHA TOCOPHEROL; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EZETIMIBE; GLYCERYL TRINITRATE; HYDRALAZINE; INDUCIBLE NITRIC OXIDE SYNTHASE; METOPROLOL SUCCINATE; METOPROLOL TARTRATE; NITRATE; NITRIC OXIDE; PERINDOPRIL; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; ROSUVASTATIN; SILDENAFIL; SPIRONOLACTONE;

ARTERIAL STIFFNESS; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTICLE; AUGMENTATION INDEX; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOPULMONARY HEMODYNAMICS; CORONARY ARTERY BLOOD FLOW; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; DRUG TARGETING; ENDOTHELIAL DYSFUNCTION; HEART CONTRACTION; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART RIGHT VENTRICLE FAILURE; HUMAN; KIDNEY CIRCULATION; KIDNEY DYSFUNCTION; MEDICAL ASSESSMENT; MORTALITY; PATHOPHYSIOLOGY; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; PULSE PRESSURE; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TONOMETRY; TREATMENT OUTCOME; VEIN OCCLUSION PLETHYSMOGRAPHY;

EID: 84867400768     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.11.082     Document Type: Review

References (240)

1. D. Lloyd-Jones, R.J. Adams, T.M. Brown Heart disease and stroke statistics - 2010 update: a report from the American Heart Association Circulation 121 2010 e46 e215
2. S.A. Hunt, W.T. Abraham, M.H. Chin ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society J Am Coll Cardiol 46 2005 e1 e82 erratum in J Am Coll Cardiol 2006;47:1503- 6
3. H. Bueno, J.S. Ross, Y. Wang Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006 JAMA 303 2010 2141 2147
4. G.C. Fonarow, E.D. Peterson Heart failure performance measures and outcomes: real or illusory gains JAMA 302 2009 792 794
5. M.S. Cuffe, R.M. Califf, K.F. Adams Jr. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial JAMA 287 2002 1541 1547
6. M. Gheorghiade, M.A. Konstam, J.C. Burnett Jr. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials JAMA 297 2007 1332 1343
7. M.A. Konstam, M. Gheorghiade, J.C. Burnett Jr. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial JAMA 297 2007 1319 1331
8. J.J. McMurray, J.R. Teerlink, G. Cotter Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials JAMA 298 2007 2009 2019
9. A. Mebazaa, M.S. Nieminen, M. Packer Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial JAMA 297 2007 1883 1891
10. J.D. Sackner-Bernstein, M. Kowalski, M. Fox, K. Aaronson Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials JAMA 293 2005 1900 1905
11. J.D. Sackner-Bernstein, H.A. Skopicki, K.D. Aaronson Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure Circulation 111 2005 1487 1491
12. M. Packer Current perspectives on the design of Phase II trials of new drugs for the treatment of heart failure Am Heart J 139 2000 S202 S206
13. M. Gheorghiade, P.S. Pang, C.M. O'Connor Clinical development of pharmacologic agents for acute heart failure syndromes: a proposal for a mechanistic translational phase Am Heart J 161 2011 224 232
14. G.M. Felker, P.S. Pang, K.F. Adams Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward Circ Heart Failure 3 2010 314 325
15. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial JAMA 287 2002 1531 1540
16. C.M. O'Connor, R.C. Starling, A.F. Hernandez The effect of nesiritide in patients with acute decompensated heart failure N Engl J Med 365 2011 32 43
17. B.M. Massie, C.M. O'Connor, M. Metra Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure N Engl J Med 363 2010 1419 1428
18. E.J. Velazquez, K.L. Lee, M.A. Deja Coronary-artery bypass surgery in patients with left ventricular dysfunction N Engl J Med 364 2011 1607 1616
19. R.O. Bonow, G. Maurer, K.L. Lee Myocardial viability and survival in ischemic left ventricular dysfunction N Engl J Med 364 2011 1617 1625
20. J.M. Hare, B. Mangal, J. Brown Impact of oxypurinol in patients with symptomatic heart failure Results of the OPT-CHF study J Am Coll Cardiol 51 2008 2301 2309
21. L. Kober, C. Torp-Pedersen, J.J. McMurray Increased mortality after dronedarone therapy for severe heart failure N Engl J Med 358 2008 2678 2687
22. G.H. Bardy, K.L. Lee, D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
23. M. Gheorghiade, F. Zannad, G. Sopko Acute heart failure syndromes: current state and framework for future research Circulation 112 2005 3958 3968
24. B.S. Wessler, D.G. Kramer, J.L. Kelly Drug and device effects on peak oxygen consumption, 6-minute walk distance, and natriuretic peptides as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction Circ Heart Fail 4 2011 578 588
25. D.G. Kramer, T.A. Trikalinos, D.M. Kent, G.V. Antonopoulos, M.A. Konstam, J.E. Udelson Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach J Am Coll Cardiol 56 2010 392 406
26. R.F. Furchgott, J.V. Zawadzki The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 288 1980 373 376
27. G.M. Rubanyi, J.C. Romero, P.M. Vanhoutte Flow-induced release of endothelium-derived relaxing factor Am J Physiol 250 1986 H1145 H1149
28. P. Libby, M. Aikawa, M.K. Jain Vascular endothelium and atherosclerosis Handb Exp Pharmacol 2006 285 306
29. S. Moncada, R.M. Palmer, E.A. Higgs Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacol Rev 43 1991 109 142
30. T.F. Lüscher, M. Barton Biology of the endothelium Clin Cardiol 20 1997 II3 II10
31. U. Ikeda, K. Shimada Nitric oxide and cardiac failure Clin Cardiol 20 1997 837 841
32. L. Agnoletti, S. Curello, T. Bachetti Serum from patients with severe heart failure downregulates eNOS and is proapoptotic: role of tumor necrosis factor-alpha Circulation 100 1999 1983 1991
33. C.J. Smith, D. Sun, C. Hoegler Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure Circ Res 78 1996 58 64
34. W.J. Paulus, J.G. Bronzwaer Nitric oxide's role in the heart: control of beating or breathing? Am J Physiol Heart Circ Physiol 287 2004 H8 H13
35. A. Aicher, C. Heeschen, C. Mildner-Rihm Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells Nat Med 9 2003 1370 1376
36. B. Datta, T. Tufnell-Barrett, R.A. Bleasdale Red blood cell nitric oxide as an endocrine vasoregulator: a potential role in congestive heart failure Circulation 109 2004 1339 1342
37. D.S. Celermajer, K.E. Sorensen, V.M. Gooch Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis Lancet 340 1992 1111 1115
38. M.C. Corretti, T.J. Anderson, E.J. Benjamin Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force J Am Coll Cardiol 39 2002 257 265
39. H. Drexler, D. Hayoz, T. Munzel Endothelial function in chronic congestive heart failure Am J Cardiol 69 1992 1596 1601
40. S.H. Kubo, T.S. Rector, A.J. Bank, R.E. Williams, S.M. Heifetz Endothelium-dependent vasodilation is attenuated in patients with heart failure Circulation 84 1991 1589 1596
41. O. Parodi, R. De Maria, E. Roubina Redox state, oxidative stress and endothelial dysfunction in heart failure: the puzzle of nitrate-thiol interaction J Cardiovasc Med (Hagerstown) 8 2007 765 774
42. D. Tousoulis, M. Charakida, C. Stefanadis Inflammation and endothelial dysfunction as therapeutic targets in patients with heart failure Int J Cardiol 100 2005 347 353
43. H. Drexler Endothelium as a therapeutic target in heart failure Circulation 98 1998 2652 2655
44. A.J. Bank, P.C. Lee, S.H. Kubo Endothelial dysfunction in patients with heart failure: relationship to disease severity J Card Fail 6 2000 29 36
45. S.D. Katz, T. Khan, G.A. Zeballos Decreased activity of the L-arginine-nitric oxide metabolic pathway in patients with congestive heart failure Circulation 99 1999 2113 2117
46. J.M. Hare, J.S. Stamler NO/redox disequilibrium in the failing heart and cardiovascular system J Clin Invest 115 2005 509 517
47. M. Ontkean, R. Gay, B. Greenberg Diminished endothelium-derived relaxing factor activity in an experimental model of chronic heart failure Circ Res 69 1991 1088 1096
48. P.M. Vanhoutte, H. Shimokawa, E.H. Tang, M. Feletou Endothelial dysfunction and vascular disease Acta Physiol (Oxf) 196 2009 193 222
49. T. Munzel, D.G. Harrison Increased superoxide in heart failure: a biochemical baroreflex gone awry Circulation 100 1999 216 218
50. J. Bauersachs, A. Bouloumie, D. Fraccarollo, K. Hu, R. Busse, G. Ertl Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production Circulation 100 1999 292 298
51. J.A. Vita Endothelial function and clinical outcome Heart 91 2005 1278 1279
52. J. Davignon, P. Ganz Role of endothelial dysfunction in atherosclerosis Circulation 109 2004 III27 III32
53. J. Bauersachs, J.D. Widder Endothelial dysfunction in heart failure Pharmacol Rep 60 2008 119 126
54. B. Meyer, D. Mortl, K. Strecker Flow-mediated vasodilation predicts outcome in patients with chronic heart failure: comparison with B-type natriuretic peptide J Am Coll Cardiol 46 2005 1011 1018
55. R. Varin, P. Mulder, F. Tamion Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure: role of nitric oxide, prostanoids, oxidant stress, and bradykinin Circulation 102 2000 351 356
56. A. Ben Driss, C. Devaux, D. Henrion Hemodynamic stresses induce endothelial dysfunction and remodeling of pulmonary artery in experimental compensated heart failure Circulation 101 2000 2764 2770
57. D.L. Moraes, W.S. Colucci, M.M. Givertz Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management Circulation 102 2000 1718 1723
58. J.E. Blair, A. Manuchehry, A. Chana Prognostic markers in heart failure - congestion, neurohormones, and the cardiorenal syndrome Acute Card Care 9 2007 207 213
59. C.B. Treasure, J.A. Vita, D.A. Cox Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy Circulation 81 1990 772 779
60. M.W. Ramsey, J. Goodfellow, C.J. Jones, L.A. Luddington, M.J. Lewis, A.H. Henderson Endothelial control of arterial distensibility is impaired in chronic heart failure Circulation 92 1995 3212 3219
61. G.F. Mitchell, J.C. Tardif, J.M. Arnold Pulsatile hemodynamics in congestive heart failure Hypertension 38 2001 1433 1439
62. N.H. Buus, M. Bottcher, F. Hermansen, M. Sander, T.T. Nielsen, M.J. Mulvany Influence of nitric oxide synthase and adrenergic inhibition on adenosine-induced myocardial hyperemia Circulation 104 2001 2305 2310
63. M. Scherrer-Crosbie, R. Ullrich, K.D. Bloch Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice Circulation 104 2001 1286 1291
64. P.B. Massion, O. Feron, C. Dessy, J.L. Balligand Nitric oxide and cardiac function: ten years after, and continuing Circ Res 93 2003 388 398
65. J. Vasquez-Vivar, B. Kalyanaraman, P. Martasek Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors Proc Natl Acad Sci U S A 95 1998 9220 9225
66. C. Hermann, A.M. Zeiher, S. Dimmeler Shear stress inhibits H2O2-induced apoptosis of human endothelial cells by modulation of the glutathione redox cycle and nitric oxide synthase Arterioscler Thromb Vasc Biol 17 1997 3588 3592
67. S.D. Katz, R. Rao, J.W. Berman Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure Relation to nitric oxide-dependent vasodilation in the forearm circulation Circulation 90 1994 12 16
68. Y. Seta, K. Shan, B. Bozkurt, H. Oral, D.L. Mann Basic mechanisms in heart failure: the cytokine hypothesis J Card Fail 2 1996 243 249
69. L. Rossig, J. Haendeler, Z. Mallat Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol J Am Coll Cardiol 36 2000 2081 2089
70. D.M. McNamara, R. Holubkov, L. Postava Effect of the Asp298 variant of endothelial nitric oxide synthase on survival for patients with congestive heart failure Circulation 107 2003 1598 1602
71. S.P. Jones, J.J. Greer, R. van Haperen, D.J. Duncker, R. de Crom, D.J. Lefer Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice Proc Natl Acad Sci U S A 100 2003 4891 4896
72. J.G. Akar, M.O. Al-Chekakie, T. Fugate Endothelial dysfunction in heart failure identifies responders to cardiac resynchronization therapy Heart Rhythm 5 2008 1229 1235
73. B.A. Borlaug, V. Melenovsky, S.D. Russell Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction Circulation 114 2006 2138 2147
74. A.L. Clark, P.A. Poole-Wilson, A.J. Coats Exercise limitation in chronic heart failure: central role of the periphery J Am Coll Cardiol 28 1996 1092 1102
75. T. Hirai, M.D. Visneski, K.J. Kearns, R. Zelis, T.I. Musch Effects of NO synthase inhibition on the muscular blood flow response to treadmill exercise in rats J Appl Physiol 77 1994 1288 1293
76. A.J. Maxwell, E. Schauble, D. Bernstein, J.P. Cooke Limb blood flow during exercise is dependent on nitric oxide Circulation 98 1998 369 374
77. A.L. Clark Origin of symptoms in chronic heart failure Heart 92 2006 12 16
78. P. Ponikowski, D.P. Francis, M.F. Piepoli Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis Circulation 103 2001 967 972
79. A.J. Coats, S. Adamopoulos, A. Radaelli Controlled trial of physical training in chronic heart failure Exercise performance, hemodynamics, ventilation, and autonomic function Circulation 85 1992 2119 2131
80. C. Sartori, Y. Allemann, U. Scherrer Pathogenesis of pulmonary edema: learning from high-altitude pulmonary edema Respir Physiol Neurobiol 159 2007 338 349
81. C. Sartori, M. Lepori, U. Scherrer Interaction between nitric oxide and the cholinergic and sympathetic nervous system in cardiovascular control in humans Pharmacol Ther 106 2005 209 220
82. J.N. Bech, C.B. Nielsen, P. Ivarsen, K.T. Jensen, E.B. Pedersen Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans Am J Physiol 274 1998 F914 F923
83. C.E. Berry, J.M. Hare Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications J Physiol 555 2004 589 606
84. M.B. Kadiiska, B.C. Gladen, D.D. Baird Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med 38 2005 698 710
85. M.B. Kadiiska, B.C. Gladen, D.D. Baird Biomarkers of oxidative stress study III Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning Free Radic Biol Med 38 2005 711 718
86. Z. Ungvari, S.A. Gupte, F.A. Recchia, S. Batkai, P. Pacher Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure Curr Vasc Pharmacol 3 2005 221 229
87. G.C. Fonarow, K.F. Adams, W.T. Abraham, C.W. Yancy, W.J. Boscardin Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis JAMA 293 2005 572 580
88. D.S. Majid, L.G. Navar Nitric oxide in the control of renal hemodynamics and excretory function Am J Hypertens 14 2001 74S 82S
89. T. Wang, F.M. Inglis, R.G. Kalb Defective fluid and HCO(3)(-) absorption in proximal tubule of neuronal nitric oxide synthase-knockout mice Am J Physiol Renal Physiol 279 2000 F518 F524
90. P.A. Ortiz, J.L. Garvin Autocrine effects of nitric oxide on HCO(3)(-) transport by rat thick ascending limb Kidney Int 58 2000 2069 2074
91. C.F. Plato, B.A. Stoos, D. Wang, J.L. Garvin Endogenous nitric oxide inhibits chloride transport in the thick ascending limb Am J Physiol 276 1999 F159 F163
92. M. Lu, X. Wang, W. Wang Nitric oxide increases the activity of the apical 70-pS K+ channel in TAL of rat kidney Am J Physiol 274 1998 F946 F950
93. M. Lu, G. Giebisch, W. Wang Nitric oxide links the apical Na+ transport to the basolateral K+ conductance in the rat cortical collecting duct J Gen Physiol 110 1997 717 726
94. N.H. Garcia, B.A. Stoos, O.A. Carretero, J.L. Garvin Mechanism of the nitric oxide-induced blockade of collecting duct water permeability Hypertension 27 1996 679 683
95. A. Tojo, N.J. Guzman, L.C. Garg, C.C. Tisher, K.M. Madsen Nitric oxide inhibits bafilomycin-sensitive H(+)-ATPase activity in rat cortical collecting duct Am J Physiol 267 1994 F509 F515
96. D.S. Majid, A. Williams, L.G. Navar Inhibition of nitric oxide synthesis attenuates pressure-induced natriuretic responses in anesthetized dogs Am J Physiol 264 1993 F79 F87
97. C.S. Wilcox, W.J. Welch, F. Murad Nitric oxide synthase in macula densa regulates glomerular capillary pressure Proc Natl Acad Sci U S A 89 1992 11993 11997
98. M.L. Blitzer, E. Loh, M.A. Roddy, J.S. Stamler, M.A. Creager Endothelium-derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humans J Am Coll Cardiol 28 1996 591 596
99. C.J. Cooper, M.J. Landzberg, T.J. Anderson Role of nitric oxide in the local regulation of pulmonary vascular resistance in humans Circulation 93 1996 266 271
100. J.S. Stamler, E. Loh, M.A. Roddy, K.E. Currie, M.A. Creager Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans Circulation 89 1994 2035 2040
101. J. Butler, D.B. Chomsky, J.R. Wilson Pulmonary hypertension and exercise intolerance in patients with heart failure J Am Coll Cardiol 34 1999 1802 1806
102. S. Ghio, A. Gavazzi, C. Campana Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure J Am Coll Cardiol 37 2001 183 188
103. C.S. Lam, V.L. Roger, R.J. Rodeheffer, B.A. Borlaug, F.T. Enders, M.M. Redfield Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study J Am Coll Cardiol 53 2009 1119 1126
104. C.C. Leung, V. Moondra, E. Catherwood, B.W. Andrus Prevalence and risk factors of pulmonary hypertension in patients with elevated pulmonary venous pressure and preserved ejection fraction Am J Cardiol 106 2010 284 286
105. S.V. Abramson, J.F. Burke, J.J. Kelly Jr. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy Ann Intern Med 116 1992 888 895
106. J. Kjaergaard, D. Akkan, K.K. Iversen Prognostic importance of pulmonary hypertension in patients with heart failure Am J Cardiol 99 2007 1146 1150
107. P. de Groote, A. Millaire, C. Foucher-Hossein Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure J Am Coll Cardiol 32 1998 948 954
108. T.G. Di Salvo, M. Mathier, M.J. Semigran, G.W. Dec Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure J Am Coll Cardiol 25 1995 1143 1153
109. M. Ontkean, R. Gay, B. Greenberg Diminished endothelium-derived relaxing factor activity in an experimental model of chronic heart failure Circ Res 69 1991 1088 1096
110. T.R. Porter, D.O. Taylor, A. Cycan Endothelium-dependent pulmonary artery responses in chronic heart failure: influence of pulmonary hypertension J Am Coll Cardiol 22 1993 1418 1424
111. C.J. Cooper, F.W. Jevnikar, T. Walsh, J. Dickinson, A. Mouhaffel, A.P. Selwyn The influence of basal nitric oxide activity on pulmonary vascular resistance in patients with congestive heart failure Am J Cardiol 82 1998 609 614
112. J.N. Cohn, A.A. Quyyumi, N.K. Hollenberg, K.A. Jamerson Surrogate markers for cardiovascular disease: functional markers Circulation 109 2004 IV31 IV46
113. P.O. Bonetti, L.O. Lerman, A. Lerman Endothelial dysfunction: a marker of atherosclerotic risk Arterioscler Thromb Vasc Biol 23 2003 168 175
114. D. Hasdai, A. Lerman The assessment of endothelial function in the cardiac catheterization laboratory in patients with risk factors for atherosclerotic coronary artery disease Herz 24 1999 544 547
115. P.L. Ludmer, A.P. Selwyn, T.L. Shook Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries N Engl J Med 315 1986 1046 1051
116. A.A. Quyyumi Endothelial function in health and disease: new insights into the genesis of cardiovascular disease Am J Med 105 1998 32S 39S
117. W. Aarnoudse, M. Van't Veer, N.H. Pijls Direct volumetric blood flow measurement in coronary arteries by thermodilution J Am Coll Cardiol 50 2007 2294 2304
118. N.H. Pijls, B. De Bruyne, L. Smith Coronary thermodilution to assess flow reserve: validation in humans Circulation 105 2002 2482 2486
119. J.O. Prior, T.H. Schindler, A.D. Facta Determinants of myocardial blood flow response to cold pressor testing and pharmacologic vasodilation in healthy humans Eur J Nucl Med Mol Imaging 34 2007 20 27
120. M. Terashima, P.K. Nguyen, G.D. Rubin Impaired coronary vasodilation by magnetic resonance angiography is associated with advanced coronary artery calcification J Am Coll Cardiol Img 1 2008 167 173
121. N. Melikian, M.T. Kearney, M.R. Thomas, B. De Bruyne, A.M. Shah, P.A. MacCarthy A simple thermodilution technique to assess coronary endothelium-dependent microvascular function in humans: validation and comparison with coronary flow reserve Eur Heart J 28 2007 2188 2194
122. I.B. Wilkinson, D.J. Webb Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications Br J Clin Pharmacol 52 2001 631 646
123. T.A. Alam, A.M. Seifalian, D. Baker A review of methods currently used for assessment of in vivo endothelial function Eur J Vasc Endovasc Surg 29 2005 269 276
124. B.M. Silva, F.J. Neves, N.G. Rocha, M. Cagy, M.N. de Souza, A.C. da Nobrega Intra- and inter-tester reproducibility of venous occlusion plethysmography: comparison between a manual and a semi-automatic method of blood flow analysis Physiol Meas 30 2009 1267 1279
125. M.J. Mullen, R.K. Kharbanda, J. Cross Heterogenous nature of flow-mediated dilatation in human conduit arteries in vivo: relevance to endothelial dysfunction in hypercholesterolemia Circ Res 88 2001 145 151
126. P. Leeson, S. Thorne, A. Donald, M. Mullen, P. Clarkson, J. Deanfield Non-invasive measurement of endothelial function: effect on brachial artery dilatation of graded endothelial dependent and independent stimuli Heart 78 1997 22 27
127. J.S. Sidhu, V.R. Newey, D.K. Nassiri, J.C. Kaski A rapid and reproducible on line automated technique to determine endothelial function Heart 88 2002 289 292
128. T.J. Anderson, A. Uehata, M.D. Gerhard Close relation of endothelial function in the human coronary and peripheral circulations J Am Coll Cardiol 26 1995 1235 1241
129. K.S. Woo, P. Chook, C.W. Yu Effects of diet and exercise on obesity-related vascular dysfunction in children Circulation 109 2004 1981 1986
130. E.J. Benjamin, M.G. Larson, M.J. Keyes Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study Circulation 109 2004 613 619
131. H. Brunner, J.R. Cockcroft, J. Deanfield Endothelial function and dysfunction Part II: association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension J Hypertens 23 2005 233 246
132. J. Deanfield, A. Donald, C. Ferri Endothelial function and dysfunction Part I: methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension J Hypertens 23 2005 7 17
133. D.H. Endemann, E.L. Schiffrin Endothelial dysfunction J Am Soc Nephrol 15 2004 1983 1992
134. J.T. Kuvin, A.R. Patel, K.A. Sliney Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude Am Heart J 146 2003 168 174
135. A. Nohria, M. Gerhard-Herman, M.A. Creager, S. Hurley, D. Mitra, P. Ganz Role of nitric oxide in the regulation of digital pulse volume amplitude in humans J Appl Physiol 101 2006 545 548
136. P.O. Bonetti, G.M. Pumper, S.T. Higano, D.R. Holmes Jr., J.T. Kuvin, A. Lerman Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia J Am Coll Cardiol 44 2004 2137 2141
137. R.B. Schnabel, A. Schulz, P.S. Wild Noninvasive vascular function measurement in the community: cross-sectional relations and comparison of methods Circ Cardiovasc Imaging 4 2011 371 380
138. R. Rubinshtein, J.T. Kuvin, M. Soffler Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events Eur Heart J 31 2010 1142 1148
139. N.M. Hamburg, M.J. Keyes, M.G. Larson Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study Circulation 117 2008 2467 2474
140. S.R. Mulukutla, L. Venkitachalam, C. Bambs Black race is associated with digital artery endothelial dysfunction: results from the Heart SCORE study Eur Heart J 31 2010 2808 2815
141. T. Heitzer, S. Baldus, Y. von Kodolitsch, V. Rudolph, T. Meinertz Systemic endothelial dysfunction as an early predictor of adverse outcome in heart failure Arterioscler Thromb Vasc Biol 25 2005 1174 1179
142. A. Prasad, S.T. Higano, J. Al Suwaidi Abnormal coronary microvascular endothelial function in humans with asymptomatic left ventricular dysfunction Am Heart J 146 2003 549 554
143. T. Bachetti Endothelial dysfunction in chronic heart failure: some new basic mechanisms Ital Heart J 1 2000 656 661
144. M.A. Mathier, G.A. Rose, M.A. Fifer Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy J Am Coll Cardiol 32 1998 216 224
145. S.D. Katz, L. Biasucci, C. Sabba Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure J Am Coll Cardiol 19 1992 918 925
146. M. Shechter, S. Matetzky, M. Arad, M.S. Feinberg, D. Freimark Vascular endothelial function predicts mortality risk in patients with advanced ischaemic chronic heart failure Eur J Heart Fail 11 2009 588 593
147. J.R. de Berrazueta, A. Guerra-Ruiz, M.T. Garcia-Unzueta Endothelial dysfunction, measured by reactive hyperaemia using strain-gauge plethysmography, is an independent predictor of adverse outcome in heart failure Eur J Heart Fail 12 2010 477 483
148. G. Poelzl, M. Frick, H. Huegel Chronic heart failure is associated with vascular remodeling of the brachial artery Eur J Heart Fail 7 2005 43 48
149. D. Fischer, S. Rossa, U. Landmesser Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death Eur Heart J 26 2005 65 69
150. S.D. Katz, K. Hryniewicz, I. Hriljac Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure Circulation 111 2005 310 314
151. S.Y. Chan, G.B. Mancini, L. Kuramoto, M. Schulzer, J. Frohlich, A. Ignaszewski The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease J Am Coll Cardiol 42 2003 1037 1043
152. J.P. Halcox, W.H. Schenke, G. Zalos Prognostic value of coronary vascular endothelial dysfunction Circulation 106 2002 653 658
153. T. Murakami, S. Mizuno, K. Ohsato Effects of troglitazone on frequency of coronary vasospastic-induced angina pectoris in patients with diabetes mellitus Am J Cardiol 84 1999 92 94 A8
154. V. Schachinger, M.B. Britten, A.M. Zeiher Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease Circulation 101 2000 1899 1906
155. J.A. Suwaidi, S. Hamasaki, S.T. Higano, R.A. Nishimura, D.R. Holmes Jr., A. Lerman Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction Circulation 101 2000 948 954
156. G. Brevetti, A. Silvestro, V. Schiano, M. Chiariello Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index Circulation 108 2003 2093 2098
157. D.S. Celermajer, K.E. Sorensen, C. Bull, J. Robinson, J.E. Deanfield Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction J Am Coll Cardiol 24 1994 1468 1474
158. R. Hambrecht, E. Fiehn, C. Weigl Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure Circulation 98 1998 2709 2715
159. J. Yeboah, J.R. Crouse, F.C. Hsu, G.L. Burke, D.M. Herrington Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study Circulation 115 2007 2390 2397
160. A.E. Donald, J.P. Halcox, M. Charakida Methodological approaches to optimize reproducibility and power in clinical studies of flow-mediated dilation J Am Coll Cardiol 51 2008 1959 1964
161. N.M. Hamburg, J. Palmisano, M.G. Larson Relation of brachial and digital measures of vascular function in the community: the Framingham Heart Study Hypertension 57 2011 390 396
162. A.S. Androne, K. Hryniewicz, A. Hudaihed Comparison of metabolic vasodilation in response to exercise and ischemia and endothelium-dependent flow-mediated dilation in African-American versus non-African-American patients with chronic heart failure Am J Cardiol 97 2006 685 689
163. C. Cardillo, C.M. Kilcoyne, R.O. Cannon 3rd, J.A. Panza Racial differences in nitric oxide-mediated vasodilator response to mental stress in the forearm circulation Hypertension 31 1998 1235 1239
164. L. Kalinowski, I.T. Dobrucki, T. Malinski Race-specific differences in endothelial function: predisposition of African Americans to vascular diseases Circulation 109 2004 2511 2517
165. P. Carson, S. Ziesche, G. Johnson, J.N. Cohn Vasodilator-Heart Failure Trial Study Group Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials J Card Fail 5 1999 178 187
166. S.J. Zieman, V. Melenovsky, D.A. Kass Mechanisms, pathophysiology, and therapy of arterial stiffness Arterioscler Thromb Vasc Biol 25 2005 932 943
167. S. Laurent, P. Boutouyrie, P. Lacolley Structural and genetic bases of arterial stiffness Hypertension 45 2005 1050 1055
168. M.F. O'Rourke, J.A. Staessen, C. Vlachopoulos, D. Duprez, G.E. Plante Clinical applications of arterial stiffness; definitions and reference values Am J Hypertens 15 2002 426 444
169. G.F. Mitchell, H. Parise, E.J. Benjamin Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study Hypertension 43 2004 1239 1245
170. R. Din-Dzietham, D. Couper, G. Evans, D.K. Arnett, D.W. Jones Arterial stiffness is greater in African Americans than in whites: evidence from the Forsyth County, North Carolina, ARIC cohort Am J Hypertens 17 2004 304 313
171. E. Agabiti-Rosei, G. Mancia, M.F. O'Rourke Central blood pressure measurements and antihypertensive therapy: a consensus document Hypertension 50 2007 154 160
172. S. Laurent, J. Cockcroft, L. Van Bortel Expert consensus document on arterial stiffness: methodological issues and clinical applications Eur Heart J 27 2006 2588 2605
173. B. Williams, P.S. Lacy, S.M. Thom Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study Circulation 113 2006 1213 1225
174. C.M.Yasmin McEniery, I.R. Hall, A. Qasem, I.B. Wilkinson, J.R. Cockcroft Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT) J Am Coll Cardiol 46 2005 1753 1760
175. W.W. Nichols, S.J. Denardo, I.B. Wilkinson, C.M. McEniery, J. Cockcroft, M.F. O'Rourke Effects of arterial stiffness, pulse wave velocity, and wave
176. B. Jiang, B. Liu, K.L. McNeill, P.J. Chowienczyk Measurement of pulse wave velocity using pulse wave Doppler ultrasound: comparison with arterial tonometry Ultrasound Med Biol 34 2008 509 512
177. F. Wiesmann, S.E. Petersen, P.M. Leeson Global impairment of brachial, carotid, and aortic vascular function in young smokers: direct quantification by high-resolution magnetic resonance imaging J Am Coll Cardiol 44 2004 2056 2064
178. G.G. Sandor, T. Hishitani, R.E. Petty A novel Doppler echocardiographic method of measuring the biophysical properties of the aorta in pediatric patients J Am Soc Echocardiogr 16 2003 745 750
179. P.J. Chowienczyk, R.P. Kelly, H. MacCallum Photoplethysmographic assessment of pulse wave reflection: blunted response to endothelium-dependent beta2-adrenergic vasodilation in type II diabetes mellitus J Am Coll Cardiol 34 1999 2007 2014
180. I.B. Wilkinson, I.R. Hall, H. MacCallum Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function Arterioscler Thromb Vasc Biol 22 2002 147 152
181. R.P. Kelly, H.H. Gibbs, M.F. O'Rourke Nitroglycerin has more favourable effects on left ventricular afterload than apparent from measurement of pressure in a peripheral artery Eur Heart J 11 1990 138 144
182. I.B. Wilkinson, H. MacCallum, J.R. Cockcroft, D.J. Webb Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo Br J Clin Pharmacol 53 2002 189 192
183. M. Schram, R. Henry, R. van Dijk Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn Study Hypertension 43 2004 176 181
184. R. Wildman, R. Mackey, A. Bostom, T. Thompson, K. Sutton-Tyrrell Measures of obesity are associated with vascular stiffness in young and older adults Hypertension 42 2003 468 473
185. M. Safar, M. Temmar, A. Kakou, P. Lacolley, S. Thornton Sodium intake and vascular stiffness in hypertension Hypertension 54 2009 203 209
186. W. Abhayaratna, M. Barnes, M. O'Rourke Relation of arterial stiffness to left ventricular diastolic function and cardiovascular risk prediction in patients > or =65 years of age Am J Cardiol 98 2006 1387 1392
187. P. Mottram, B. Haluska, R. Leano, S. Carlier, C. Case, T. Marwick Relation of arterial stiffness to diastolic dysfunction in hypertensive heart disease Heart 91 2005 1551 1556
188. W. Hundley, D. Kitzman, T. Morgan Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance J Am Coll Cardiol 38 2001 796 802
189. T. Weber, J. Auer, M. O'Rourke, C. Punzengruber, E. Kvas, B. Eber Prolonged mechanical systole and increased arterial wave reflections in diastolic dysfunction Heart 92 2006 1616 1622
190. M.M. Redfield, S.J. Jacobsen, B.A. Borlaug, R.J. Rodeheffer, D.A. Kass Age- and gender-related ventricular-vascular stiffening: a community-based study Circulation 112 2005 2254 2262
191. T. Weber, M.F. O'Rourke, M. Ammer, E. Kvas, C. Punzengruber, B. Eber Arterial stiffness and arterial wave reflections are associated with systolic and diastolic function in patients with normal ejection fraction Am J Hypertens 21 2008 1194 1202
192. I. Ikonomidis, S. Tzortzis, T. Papaioannou Incremental value of arterial wave reflections in the determination of left ventricular diastolic dysfunction in untreated patients with essential hypertension J Hum Hypertens 22 2008 687 698
193. H. Fukuta, N. Ohte, K. Wakami Impact of arterial load on left ventricular diastolic function in patients undergoing cardiac catheterization for coronary artery disease Circ J 74 2010 1900 1905
194. M.J. Roman, R.B. Devereux, J.R. Kizer Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study Hypertension 50 2007 197 203
195. G.F. Mitchell, L.A. Moye, E. Braunwald Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function SAVE investigators. Survival and Ventricular Enlargement Circulation 96 1997 4254 4260
196. M.J. Domanski, G.F. Mitchell, J.E. Norman, D.V. Exner, B. Pitt, M.A. Pfeffer Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction J Am Coll Cardiol 33 1999 951 958
197. C.U. Chae, M.A. Pfeffer, R.J. Glynn, G.F. Mitchell, J.O. Taylor, C.H. Hennekens Increased pulse pressure and risk of heart failure in the elderly JAMA 281 1999 634 639
198. S.G. Lage, L. Kopel, M.C. Monachini Carotid arterial compliance in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy Am J Cardiol 74 1994 691 695
199. A.A. Voors, C.J. Petrie, M.C. Petrie Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure Eur Heart J 26 2005 1759 1764
200. B. Hornig, V. Maier, H. Drexler Physical training improves endothelial function in patients with chronic heart failure Circulation 93 1996 210 214
201. M. Schwarz, S.D. Katz, L. Demopoulos Enhancement of endothelium-dependent vasodilation by low-dose nitroglycerin in patients with congestive heart failure Circulation 89 1994 1609 1614
202. M. Nakamura, T. Funakoshi, N. Arakawa, H. Yoshida, S. Makita, K. Hiramori Effect of angiotensin-converting enzyme inhibitors on endothelium-dependent peripheral vasodilation in patients with chronic heart failure J Am Coll Cardiol 24 1994 1321 1327
203. C.A. Farquharson, A.D. Struthers Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure Circulation 101 2000 594 597
204. S.D. Katz, K. Balidemaj, S. Homma, H. Wu, J. Wang, S. Maybaum Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure J Am Coll Cardiol 36 2000 845 851
205. R. Joannides, C. Bizet-Nafeh, A. Costentin Chronic ACE inhibition enhances the endothelial control of arterial mechanics and flow-dependent vasodilatation in heart failure Hypertension 38 2001 1446 1450
206. B. Falskov, T.S. Hermann, J. Raunso Endothelial function is unaffected by changing between carvedilol and metoprolol in patients with heart failure - a randomized study Cardiovasc Diabetol 10 2011 91
207. W. Doehner, N. Schoene, M. Rauchhaus Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies Circulation 105 2002 2619 2624
208. C.A. Farquharson, R. Butler, A. Hill, J.J. Belch, A.D. Struthers Allopurinol improves endothelial dysfunction in chronic heart failure Circulation 106 2002 221 226
209. A.K. Abiose, G.A. Mansoor, M. Barry, R. Soucier, C.K. Nair, D. Hager Effect of spironolactone on endothelial function in patients with congestive heart failure on conventional medical therapy Am J Cardiol 93 2004 1564 1566
210. J.E. Macdonald, N. Kennedy, A.D. Struthers Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment Heart 90 2004 765 770
211. D. Tousoulis, C. Antoniades, C. Vassiliadou Effects of combined administration of low dose atorvastatin and vitamin E on inflammatory markers and endothelial function in patients with heart failure Eur J Heart Fail 7 2005 1126 1132
212. J. George, E. Carr, J. Davies, J.J. Belch, A. Struthers High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid Circulation 114 2006 2508 2516
213. M. Guazzi, M. Samaja, R. Arena, M. Vicenzi, M.D. Guazzi Long-term use of sildenafil in the therapeutic management of heart failure J Am Coll Cardiol 50 2007 2136 2144
214. P.F. Castro, R. Miranda, H.E. Verdejo Pleiotropic effects of atorvastatin in heart failure: role in oxidative stress, inflammation, endothelial function, and exercise capacity J Heart Lung Transplant 27 2008 435 441
215. P. Gounari, D. Tousoulis, C. Antoniades Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering Int J Cardiol 142 2010 87 91
216. S. Erbs, E.B. Beck, A. Linke High-dose rosuvastatin in chronic heart failure promotes vasculogenesis, corrects endothelial function, and improves cardiac remodeling - results from a randomized, double-blind, and placebo-controlled study Int J Cardiol 146 2011 56 63
217. B. Hornig, U. Landmesser, C. Kohler Comparative effect of ACE inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase Circulation 103 2001 799 805
218. J. Bauersachs, M. Heck, D. Fraccarollo Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expression J Am Coll Cardiol 39 2002 351 358
219. L. Rossig, J. Haendeler, Z. Mallat Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol J Am Coll Cardiol 36 2000 2081 2089
220. K. Nakamura, K. Kusano, Y. Nakamura Carvedilol decreases elevated oxidative stress in human failing myocardium Circulation 105 2002 2867 2871
221. A. Daiber, A. Mulsch, U. Hink The oxidative stress concept of nitrate tolerance and the antioxidant properties of hydralazine Am J Cardiol 96 2005 25i 36i
222. K. Hirata, A. Adji, C. Vlachopoulos, M.F. O'Rourke Effect of sildenafil on cardiac performance in patients with heart failure Am J Cardiol 96 2005 1436 1440
223. B.A. Borlaug, V. Melenovsky, T. Marhin, P. Fitzgerald, D.A. Kass Sildenafil inhibits beta-adrenergic-stimulated cardiac contractility in humans Circulation 112 2005 2642 2649
224. M. Guazzi, G. Tumminello, F. Di Marco, C. Fiorentini, M.D. Guazzi The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure J Am Coll Cardiol 44 2004 2339 2348
225. G.D. Lewis, J. Lachmann, J. Camuso Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure Circulation 115 2007 59 66
226. O.V. Evgenov, P. Pacher, P.M. Schmidt, G. Hasko, H.H. Schmidt, J.P. Stasch NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential Nat Rev Drug Discov 5 2006 755 768
227. J.P. Stasch, K. Dembowsky, E. Perzborn, E. Stahl, M. Schramm Cardiovascular actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: in vivo studies Br J Pharmacol 135 2002 344 355
228. G. Boerrigter, L.C. Costello-Boerrigter, A. Cataliotti Cardiorenal and humoral properties of a novel direct soluble guanylate cyclase stimulator BAY 41-2272 in experimental congestive heart failure Circulation 107 2003 686 689
229. H. Lapp, V. Mitrovic, N. Franz Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure Circulation 119 2009 2781 2788
230. G. Boerrigter, L.C. Costello-Boerrigter, A. Cataliotti, H. Lapp, J.P. Stasch, J.C. Burnett Jr Targeting heme-oxidized soluble guanylate cyclase in experimental heart failure Hypertension 49 2007 1128 1133
231. D.A. Duprez Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review J Hypertens 24 2006 983 991
232. L.M. Resnick, M.H. Lester Differential effects of antihypertensive drug therapy on arterial compliance Am J Hypertens 15 2002 1096 1100
233. G. Bakris An in-depth analysis of vasodilation in the management of hypertension: focus on adrenergic blockade J Cardiovasc Pharmacol 53 2009 379 387
234. A. Mahmud, J. Feely Antihypertensive drugs and arterial stiffness Expert Rev Cardiovasc Ther 1 2003 65 78
235. J.N. Cohn, D.J. Wilson, J. Neutel Coadministered amlodipine and atorvastatin produces early improvements in arterial wall compliance in hypertensive patients with dyslipidemia Am J Hypertens 22 2009 137 144
236. E. Grossman, F.H. Messerli Long-term safety of antihypertensive therapy Prog Cardiovasc Dis 49 2006 16 25
237. B. Assmus, U. Fischer-Rasokat, J. Honold Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry Circ Res 100 2007 1234 1241
238. V. Subramaniyam, E.K. Waller, J.R. Murrow Bone marrow mobilization with granulocyte macrophage colony-stimulating factor improves endothelial dysfunction and exercise capacity in patients with peripheral arterial disease Am Heart J 158 2009 53 60.e1
239. A.E. Donald, J.P. Halcox, M. Charakida Methodological approaches to optimize reproducibility and power in clinical studies of flow-mediated dilation J Am Coll Cardiol 51 2008 1959 1964
240. M. Jessup Defining success in heart failure: the end-point mess Circulation 121 2010 1977 1980